Nipent and tumour lysis syndrome Patient Reports February 13, 2012

Nipent Side Effects Report #4708664-X
Nipent side effect was reported by a Health Professional from UNITED STATES on June 30, 2005. Male patient, 73 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent. After drug was administered, patient experienced the following side effects: dehydration, fluid intake reduced, malaise, pyrexia, tumour lysis syndrome. Nipent dosage: 7.6 MG, INTRAVENOUS. During the same period patient was treated with CYTOXAN, ALEVE, ASPIRIN, FLOMAX, PROCARDIA, LOZOL, ALLOPURINOL, COMPAZINE. Patient was hospitalized. Patient recovered.

Nipent Side Effects Report #4732526-5
Nipent side effect was reported by a Health Professional from UNITED STATES on July 29, 2005. Male patient, 73 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent. After drug was administered, patient experienced the following side effects: dehydration, fluid intake reduced, malaise, pyrexia, tumour lysis syndrome. Nipent dosage: (7.6 MG), INTRAVENOUS. During the same period patient was treated with CYTOXAN, RITUXAN, ALEVE, ASPIRIN, FLOMAX, PROCARDIA, LOZOL, ALLOPURINOL. Patient was hospitalized. Patient recovered.

Nipent Side Effects Report #4777451-9
Nipent side effect was reported by a Health Professional from UNITED STATES on Sept 09, 2005. Male patient, 73 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent. After drug was administered, patient experienced the following side effects: dehydration, fluid intake reduced, malaise, pyrexia, tumour lysis syndrome. Nipent dosage: (7.6 MG), INTRAVENOUS. During the same period patient was treated with CYTOXAN, RITUXAN, ALEVE, ASPIRIN, FLOMAX, PROCARDIA, LOZOL, ALLOPURINOL. Patient was hospitalized. Patient recovered.

Nipent Side Effects Report #5113825-4
Nipent side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 14, 2006. Male patient, 70 years of age, weighting 198.4 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent. After drug was administered, patient experienced the following side effects: renal failure, tumour lysis syndrome. Nipent dosage: 0.1905 MG/M2 (4 MG/M2, 1 IN 21 D), INTRAVENOUS. During the same period patient was treated with RITUXAN, CYCLOPHOSPHAMIDE, ACYCLORVIR, ALLOPURINOL, BACTRIM, LASIC, LASIX. Patient was hospitalized. Patient recovered.


Nipent Side Effects Report #5038182-3
Nipent side effect was reported by a Physician from UNITED STATES on June 15, 2006. Female patient, 64 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent. After drug was administered, patient experienced the following side effects: blood potassium increased, blood uric acid increased, dialysis , dyspnoea, metabolic acidosis, renal failure acute, sepsis , tumour lysis syndrome. Nipent dosage: unknown. During the same period patient was treated with RITUXAN, CYTOXAN. Patient was hospitalized. Patient died on 10/14/2005.